Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280,499 | 179,338 | 141,666 | 144,121 | 169,236 |
| Marketable Securities | N/A | N/A | N/A | 1,966 | 2,029 |
| Receivables | 60,191 | 66,238 | 96,043 | 83,659 | 48,054 |
| Inventories | 65,674 | 14,643 | 15,161 | 14,661 | 12,722 |
| Income taxes - deferred | 1,710 | N/A | 1,264 | 1,735 | 2,638 |
| TOTAL | $432,175 | $273,115 | $263,347 | $254,418 | $243,493 |
| Non-Current Assets | |||||
| PPE Net | 313,979 | 264,240 | 241,764 | 208,973 | 152,701 |
| Intangibles | 110,929 | 44,102 | 5,502 | 5,502 | 5,029 |
| Other Non-Current Assets | 81,608 | 45,173 | 53,617 | 77,971 | 99,096 |
| TOTAL | $506,516 | $353,515 | $300,883 | $292,446 | $256,826 |
| Total Assets | $938,691 | $626,630 | $564,230 | $546,864 | $500,319 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 4,470 | 5,360 | 17,187 |
| Accounts payable and accrued liabilities | 40,930 | 27,521 | 31,297 | 40,530 | 25,409 |
| Accrued Expenses | 37,928 | 25,867 | 24,214 | 22,054 | 25,284 |
| Other current liabilities | 8,733 | 1,341 | N/A | 1,748 | 0 |
| TOTAL | $92,936 | $56,651 | $61,907 | $71,054 | $75,719 |
| Non-Current Liabilities | |||||
| Long Term Debt | 251,000 | 62,000 | 58,304 | 54,094 | 30,239 |
| Deferred Revenues | 5,345 | 1,834 | 1,811 | 1,362 | 7,839 |
| Other Non-Current Liabilities | 35,841 | 18,271 | 7,272 | 11,895 | 20,928 |
| TOTAL | $292,554 | $80,814 | $60,195 | $59,083 | $51,039 |
| Total Liabilities | $385,490 | $137,465 | $122,102 | $130,137 | $126,758 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,918 | 36,772 | 35,926 | 36,015 | 35,128 |
| Common Shares | 38 | 37 | 36 | 36 | 35 |
| Retained earnings | 288,269 | 251,528 | 220,393 | 196,869 | 173,850 |
| Other shareholders' equity | -3,328 | -4,037 | -3,265 | -832 | 1,987 |
| TOTAL | $553,201 | $489,165 | $442,128 | $416,727 | $373,561 |
| Total Liabilities And Equity | $938,691 | $626,630 | $564,230 | $546,864 | $500,319 |